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PERBANDINGAN DINAMIK KOLONISASI BAGI STRAIN V AKSIN Vibrio 
cholerae SECARA IN VIVO DAN IN VITRO 
ABSTRAK 
Vibrio cholerae merupakan mikroorganisma gram negatif yang menyebabkan 
penyakit taun. Penyakit taun ialah penyakit cirit-birit yang teruk dan berkeupayaan meragut 
nyawa pesakit jika pesakit tidak mengambil rawatan dengan segera. Pelbagai jenis vaksin 
telah dibangunkan dengan menggunakan V. cholerae yang mati dan yang dilemahkan. 
Namun, tahap keberkesanan vaksin ini masih tidak konsisten dan tidak dapat memberi 
perlindungan sepanjang umur. Selain itu, terdapat vaksin di pasaran yang masih tidak dapat 
digunakan untuk mencegah kumpulan 0139 V. cho/erae, yang merupakan kumpulan yang 
paling bahaya. Maka, dalam kajian ini, beberapa strain vaksin bagi Vibrio cholerae, yang 
didapati daripada kumpulan 0139 Vibrio cholerae dengan adanya mutasi pada beberapa 
gen toksinnya digunakan untuk membelajari patogenesis penyakit taun. Kajian sitotoksisiti 
dijalankan untuk mengesahkan peranan toksin RTX yang menyebabkan sel HEp-2 menjadi 
bulat. Tambahan pula, SDS-PAGE dan Western Blot dijalankan untuk pengesahan lanjutan 
terhadap ciri-ciri toksin RTX yang menyebabkan depolimerisasi terhadap aktin dan 
penyilangan antara monomer aktin. VCUSM 9P, VCUSM liP, VCUSM 14P dan VCUSM 
17P menyebabkan kesan bulatan pada sel HEp-2, depolimerisasi terhadap aktin dan 
penyilangan antara monomer aktin. VCUSM 1 Op yang mempunyai mutasi pada kedua-dua 
gen rtx A dan C, tidak menunjukkan kesan toksin RTX terhadap sel HEp-2. Selain itu, 
untuk menkaji patogenesis penyakit taun, kedua-dua kajian kolonisasi in vivo dan in vitro 
dijalankan dan keberkesanan kolonisasi bagi bakteria dalam kedua-dua kajian 
dibandingkan. Keputusan menunjukkan kolonisasi bagi strain vaksin V. cholerae dalam 
kajian in vitro Iebih berkesan daripada kajian kolonisasi in vivo. 
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THE COMPARISON OF COLONIZATION DYNAMIC OF 
Vibrio cholerae VACCINE CANDIDATES IN VIVO AND IN VITRO 
ABSTRACT 
Vibrio cholerae is a Gram-negative bacterial pathogen that can cause cholera. 
Cholera is characterized by a severe watery diarrhea and it is a life-threatening diarrheal 
disease that eventually kills the victims within hours of the onset of symptoms if not treated 
on time. There are many killed and live-attenuated vaccines developed for V. cho/erae, but 
the efficacy of these vaccines varies and does not give life long protection. However, there 
is still no commercially available vaccine for 0139 V. cho/erae serogroup, which is the 
most virulent strain. Thus, in this study, several V. cholerae vaccine candidates which were 
derivatives of the 0139 Vibrio cholerae serogroup with the mutation on different virulence 
factors were used to study the cholera pathogenesis. The cytotoxicity assay was carried out 
to confirm the role of RTX toxin which causes the rounding effect on the HEp-2 cells. 
SDS-PAGE and Western Blot were carried out to further examine the RTX toxin property 
in causing depolymerization of actin and cross-linking of actin monomers. VCUSM 9P, 
VCUSM liP, VCUSM 14P and VCUSM 17P caused rounding of the HEp-2 cells, 
depolymerization of actin and cross-linking of actin monomers. VCUSM 1 OP which has 
mutation on both rtx A and C genes showed no effect of the RTX toxin to the HEp-2 cells. 
In the cholera pathogenesis study, both in vivo and in vitro colonization assays were 
performed and the colonization efficiency of the bacteria in both methods were compared. 
The results showed that the colonization of V. cholerae vaccine candidates in the in vitro 




1.1 Vibrio cholerae and its structure 
Vibrios are a group of Gram-negative, curved or straight motile rods that are 
normally found in the aquatic environment (Uma et al., 2003). Robert Koch obtained pure 
cultures of Vibrio cholerae and stated that V. cholerae was a little bent microorganism that 
resembled a comma or a spiral and it was highly motile with a single polar flagellum on 
gelatine plates. Besides, V. cholerae is a non-spore forming bacterium and possess 
filamentous pili that form bundles on the bacterial surface. It belongs to a family of pili 
whose chemical structure is similar to those of the gonococcus, and a number of other 
bacterial pathogens. (Thompson et al., 2004, Angelichio et al., 1999, Guentzel and Berry, 
1975). 
Several tests have been carried out to determine the biochemical properties of V. 
cholerae. This bacterium can grow on marine agar and on thiosulfate-citrate-bile salt-
sucrose agar (TCBS) selective medium. TCBS is an ideal for the selective isolation and 
purification of V. cholerae, utilizes sucrose and forms yellow colonies on this medium. V. 
cholerae can grow in aerobic or anaerobic conditions. This bacterium also shows oxidase 
positive reaction. Besides, V. cholerae has a low tolerance for acid, but can grow well in 
alkaline (pH8.0-9 .5) conditions which inhibit many other Gram-negative bacteria. V. 
cholerae ts distinguished from other vibrios by its biochemical reactions, 
1 
lipopolysaccharide (LPS) 0 antigenic structure, and production of cholera toxin (CT). 
There is over 200 recognized Vibrio cholerae 0 antigen serogroups, essentially only 0 I 
and 0139 can cause severe cholera (Liang eta/., 2003, Uma et al., 2003, Nesper et al., 
2002). 
V. cholerae as a species includes both pathogenic and non-pathogenic strains that 
vary in their virulence gene content. This bacterium is thought to contain a wide variety of 
strains and biotypes. It might receive and transfer genes for toxins, colonization factors, 
antibiotic resistance, capsular polysaccharides that provide resistance to chlorine and new 
surface antigens, such as the 0139 lipopolysaccharide and 0 antigen capsule. Many genes 
associated with virulence in cholera are known to have been acquired through gene-transfer 
events that have mediated the transformation of avirulent strains to those capable of causing 
outbreaks of diarrhea (Uma et a/., 2003 ). The lateral or horizontal transfer of these 
virulence genes by phage, pathogenicity islands inside the gene and other accessory genetic 
elements provide insights into how bacterial pathogens emerge and evolve to become new 
strains (Heidelberg et a/., 2000). 
2 
1.2 Nomenclature 
In the past, a wide variety of Gram-negative and rod-shaped bacteria with polar 
flagella were classified under the genus Vibrio (Faruque et a!. , 1998). However, V. 
cholerae is further classified into serogroups based on its somatic antigen, which is known 
as 0 antigens (Uma et al., 2003). Serogroup 01 was supposed to include all the strains that 
were responsible for epidemic and endemic cholera. It has three serotypes which include 
Inaba, Ogawa and Hikoj ima. The Hikojima serotype was rarely reported. These serotypes 
can be further distinguished into two biotypes, namely classical and El Tor based on 
biochemical properties, phenotypic differences and susceptibility to bacteriophages (Liang 
eta!. , 2003, Uma eta!. , 2003, Lin et al. , 1999, Faruque et al. , 1998, Nair eta!., 1994 ). 
Some known serogroups ofnon-01 vibrios was also reported. These vibrios possess 
biochemical and morphological characteristics very similar to those of the cholera vibrio 
but are nonagglurinable with polyvalent 01 antiserum. These vibrios are only agglutinable 
with their own antisera. Usually, non-01 serogroups of V. cholerae had been associated 
mostly with sporadic cases of diarrhea and extraintestinal infections until 1993, when a 
large cholera-like outbreak in Bangladesh and India (Uma et a!., 2003) was found to be 
caused by a Vibrio cholerae non-01 strain. This organism did not belong to any of the 
known 0 serogroups of V cholerae but to a new serogroup, which was later designated as 
0139. Since then. Vibrio cholerae 0139 has been persisting as a second etiologic agent of 
cholera (Faruque et a!. , 1998, Nair et al., 1994). Until today, the Vibrio cholerae El Tor 
biotype is still the main pathogen causing epidemics and isolated cases of cholera (Liang et 
al., 2003, Uma et al. , 2003). 
3 
Vibrio cholerae Serovers 
~ 1 ~ 
01 0139 Non-01 
I 
~ ~ l 
Ogawa Inaba Hikojima 
~ ~ ~ 
biotype biotype biotype 
' 
I I 
~ ~ ~ l ~ l 
Classical El Tor Classical El Tor Classical El Tor 
Figure 1.2.1: Schematic diagram of Vibrio cholerae classification 
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1.3 Vibrio cholerae and its epidemiology 
Cholera is a severely dehydrating diarrheal condition and this disease is epidemic, 
endemic and pandemic in nature. The epidemic forms of the disease are caused by the 01 
and 0139 serogroups of Vibrio cholerae (Uma et al., 2003). 
Epidemic cholera is spread primarily through contaminated water under conditions 
of poor sanitation, particularly where sewage treatment is absent or defective. The disease 
is now endemic, claiming thousands of lives every year, of which the vast majority occur in 
children (Faruque et al., 1998). Hallmarks of the epidemiology of cholera include a high 
degree of clustering of cases by location and season, highest rates of infection among 
children between 1 to 5 years of age in areas of endemic infection, antibiotic resistance 
patterns that frequently change from year to year and clonal diversity of epidemic strains 
(Faruque et al., 1998). 
Cholera can cause the death of a healthy adult within hours of onset (Lencer, 2001 ). 
Eight worldwide pandemics have been documented since the mid-nineteenth century and 
each pandemic lasting 5 to 25 years (Faruque et al., 1998). Cholera is endemic in the Indian 
subcontinent and Africa. Over the past two centuries, it spread beyond this historic locale to 
other parts of Asia, Indonesia, and Europe (Faruque et al., 1998). Besides, cholera is also 
endemic in southern Asia and parts of Africa (Chow et a/., 2001) as well as Latin America, 
where seasonal outbreaks occur widely and are particularly associated with poverty and 
poor sanitation. Cholera has been epidemic in southern Asia for at least 1 ,000 years, and 
has also spread worldwide to cause eight pandemics since 1817 (Heidelberg eta/., 2000). 
5 
A distinctive epidemiological feature of cholera is its appearance in a regular 
seasonal pattern in areas of endemic infection and in explosive outbreaks starting in several 
distinct foci simultaneously, indicating possible role of environmental factors in triggering 
the epidemic process (Faruque eta!., 1998). Environmental and climactic factors have been 
shown to contribute to the epidemic spread of V cholerae. In areas where it is endemic, 
cholera occurs in recurrent peaks at the end of the monsoon season. These peaks have been 
linked to water temperature changes and zooplankton blooms as well as to the prevalence 
of vibriophages in the environment (A lam et a!., 2005). Thus, cholera has been categorized 
as one of the "emerging and reemerging infections" threatening many developing countries. 
However, according to Nair et al. (1994), the pandemic potential of the Vibrio 
cholerae 0139 serogroup is obvious with the spread of this serogroup to several countries 
in the Asian and neighboring subcontinents, including Thailand and Pakistan. Furthermore, 
imported cases of 0139 cholera have been reported from the United States, United 
Kingdom, Singapore,_ Switzerland, Germany, and Japan. 
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Figure 1.3.1: Countries/areas with cholera cases from 2004-2007 (WHO, 2007) 
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1.4 Ecology of Vibrio cholerae 
V. cholerae is a gram-negative bacterium that naturally inhabits the aquatic 
environment and infects human beings (Uma et al., 2003). It is the causative agent of 
cholera, a devastating diarrheal disease that affects millions of people in the world each 
year (Hsiao et al., 2006, Chakraborty et al., 2001 ). V. cholerae has been regarded as a 
member of a group of organisms whose major habitats are aquatic ecosystems (Faruque et 
al., 2004, Faruque et al., 1998), including estuaries, marine coastal waters and sediments, 
and aquaculture settings worldwide (Thompson et al., 2004, Kierek and Watnick, 2003, 
Heidelberg et al., 2000). Besides, Vibrio cholerae is normally found in association with 
planktonic species in surface water (Hsiao et al., 2006, Merrell et al., 2000). However, 
virulent Vibrio cholerae now lurks in coastal waters throughout the hemisphere and in the 
drinking water of locales with poor sanitation. Thus, water is clearly a vehicle for 
transmission of Vibrio cholerae (Faruque eta/., 2004). 
1.5 Vibrio cholerae and the mode of transmission 
The pathogenic bacterial strains are able to colonize human small intestine and 
release cholera toxin, resulting in a secretory diarrhea that can be fatal in the absence of 
proper treatment. V. cholerae is unique among the bacterial diarrheal pathogens in its 
ability to cause worldwide pandemics of disease (Alam et a/., 2005). Thus, the factors that 
facilitate the organism's departure from the aquatic environment and promote the epidemic 
spread of human disease are of great interest. 
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Vibrios are ubiquitous in aquatic settings and that many forms of vibrios are non-
pathogenic for human. However, some strains of V. cholerae infect human and cholera is 
one of the major causes of morbidity and mortality in developing and underdeveloped 
countries (Chakraborty eta/., 2001). This disease is spread through contaminated water and 
food (Sheahan et a/., 2004, Thompson et a/., 2004, Merrell et a/., 2000). According to the 
report of World Health Organization (WHO), the sudden large outbreaks of this disease are 
usually caused by a contaminated water supply. The cholera that is transmitted by direct 
person-to-person contact rarely occurs. In highly endemic areas, it is mainly a disease of 
young children and it rarely affects breastfeeding infants. 
V. cholerae is often found in the aquatic environment and is part of the normal flora 
of brackish water and estuaries. It is often associated with algae blooms (plankton), which 
are influenced by the temperature of the water. However, cholera may transmit through its 
vectors which include zooplankton such as copepods, chironomid insects, and 
cyanobacteria {Thompson et a/., 2004). Naturally, human beings are also one of the 
reservoirs of the pathogenic form of V. cholerae (Merrell et a/., 2000). 
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1.6 Vibrio cholerae and its pathogenesis 
Cholera is the consequence of the action of toxin produced by Vibrio cholerae in 
the small intestine of humans. The toxin has been isolated and characterized, and its mode 
of action, activation of host adenylate cyclase and consequent hypersecretion of electrolytes 
and water, is reasonably well understood (Nelson et al., 1976). In human cholera, infecting 
V. cholerae is confined to the mucosa and lumen of the intestinal tract. This bacterium may 
possess a mechanism which confers upon the cells the capacity to attach to and readily 
proliferate on the surface of the intestinal epithelium of infected hosts (Guentzel and Berry, 
1975). The organisms elaborate a protein enterotoxin which mediates the net fluid secretion 
manifested as acute diarrhea. Fluid loss originates entirely in the small intestines and 
primarily in the jejunum (Baselski et a/., 1978). 
To produce disease, V. cholerae must reach the small intestine in sufficient numbers 
to multiply and colonize. Colonization of the entire intestinal tract from the jejunum to the 
colon by V. cholerae requires organism adherence to the epithelial surface. V. cholerae 
moves along and attaches to surfaces with the aid of the flagellum and pili, which act as 
adhesins. This bacterium forms microcolonies on surface and subsequently produces 
exopolysaccharides, which stabilize the pillars of the biofilm {Thompson et a/., 2004 ). The 
outstanding feature of V. cholerae pathogenicity is the ability of virulent strains to secrete 
cholera toxin (CT), which is responsible for the disease cholera (Merrell et a/., 2000, 
Faruque eta/., 1998). CT causes water and electrolyte shift from the cell to the intestinal 
lumen which is the fundamental cause of watery diarrhea of cholera. Thus, cholera 
pathogenesis relies on the synergistic effect of a number of pathogenic factors produced by 
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toxigenic V. cholerae (Faruque et al., 1998) such as the factors that produced by CTX 
element and TCP pathogenicity island in the gene. 
In general, the important steps of infection include ingestion of V. cholerae along 
with contaminated food or water, passage through the gastric acid barrier of the stomach, 
penetration through the intestinal mucus lining, adherence to intestinal epithelial cells, 
multiplication, and the production of cholera toxin (Nesper et al., 2002). Finally, the action 
of the cholera toxin will cause the disease on the victims. 
1. 7 Clinical aspects of cholera disease 
Cholera is characterized by a severe watery diarrhea caused by toxigenic bacterium 
V. cholerae, which colonizes the small intestine and produces an enterotoxin which is 
known as cholera toxin (Faruque et al., 1998). Typical cholera has a rapid onset, beginning 
with abdominal fullness and discomfort, rushes of peristalsis, and loose stools. Vomiting 
may also occur. The stools quickly become watery, voluminous, almost odorless, and 
contain mucus flecks, giving it an appearance called rice-water stools. Clinical features of 
cholera result from the extensive fluid loss and electrolyte imbalance, which can lead to 
extreme dehydration, hypotension, and death within hours if untreated. 
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1.8 Prevention and control of cholera disease 
Epidemic cholera is a disease of poor sanitation and water supply. It does not persist 
where treatment and disposal of human waste is adequate. When cholera appears in a 
community, it is important to ensure that hygienic disposal of human faeces, an adequate 
supply of clean drinking water, and good food hygiene. Cholera disease can be prevented 
by drinking boiled water. Since good sanitary conditions do not exist in many parts of the 
world, secondary local measures such as boiling or chlorination of water during epidemics 
are required. Besides, the water supply systems should incorporate filtration of drinking 
water in order to remove the bacteria. 
Effective food hygiene measures include cooking food thoroughly and eating it 
while still hot. Besides, to prevent the infection, people are advised to avoid cooked foods 
from being contaminated by contact with raw foods, contaminated surfaces or flies. 
Consumption of raw fruits should be reduced, unless they are first peeled. The cases 
associated with crustaceans can be prevented by adequate cooking. 
The proper sanitation management program to ensure supply of uncontaminated 
water is one of the means to prevent the outbreak of the cholera disease (Reidl and Klose, 
2002). The essential features of a national diarrhea diseases control programme include a 
national epidemic control committee, a well-established surveillance system, environmental 
sanitation and safe water supplies, health education, and hands-on training in clinical 
management should be emphasized. Since cholera is a water-home disease, environmental 
monitoring for the presence of V. cholerae strains with pathogenic potential is also 
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important to identify the source of strains causing either epidemics of cholera or sporadic 
cases of cholera (Faruque eta/., 2004). 
Vaccination against cholera is a powerful and feasible disease prevention strategy 
because recovery from infection results in long-term protective immunity (Liang et al., 
2003). Vaccines prepared from killed or live attenuated vibrio strains have the potential to 
stimulate the local lgA immune response. The first live attenuated vaccine developed for V. 
cholera was CVD 1 03-HgR that was designated for 01 serogroup (Favre et al., 1996). 
Later, Peru-15 was also produced as a vaccine candidate for 01 serogroup (Qadri et al., 
2005). 
1.9 Background of Vibrio cholerae 
In 1854, Vibrio cholerae was discovered by Filippo Pacini, an Italian physician. He 
identified V. cho/erae as the causative agent of cholera while studying the outbreak of this 
disease in Florence. He further pointed out that cholera was a contagious disease after he 
examined the intestinal mucosa of fatal victims of cholera by using microscope and 
detected Vibrio cholerae in all samples (Thompson eta/., 2004). Toxigenic strain of the 
Gram-negative bacterium V. cholerae causes a life-threatening diarrheal disease that can 
kill its victims within hours of the onset of symptoms. 
Prior to 1992, two biotypes of Vibrio cho/erae serogroup 01, classical and El Tor, 
were responsible for all epidemic cholera (Jouravleva et a/., 1998). The vibrio responsible 
for the seventh pandemic is known as Vibrio cholerae 01, biotype El Tor. This bacterium 
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is responsible for Asiatic or epidemic cholera and it is a well-recognized cause of morbidity 
and mortality throughout the world (Johnson et al., 1994). The seventh pandemic began in 
1961 when the vibrio first appeared as a cause of epidemic cholera in Celebes (Sulawesi), 
Indonesia. The disease then spread rapidly to other countries of eastern Asia and reached 
Bangladesh in 1963, India in 1964, and the USSR, Iran and Iraq in 1965-1966. In 1970 
cholera invaded West Africa and in 1991 cholera struck Latin America. 
Initial reports stated that until 1992, only Vibrio cholerae serogroup 0 I caused 
epidemic cholera. Some other serogroups could cause sporadic cases of diarrhea, but not 
epidemic cholera. Late in I992, large outbreaks of cholera occurred in southern and eastern 
India as well as southern Bangladesh (Johnson et a/., 1994) that were caused by a 
previously unrecognized serogroup of V. cho/erae, and then designated as 0139, 
synonymous with the Bengal strain. Since then, 0139 outbreaks have occurred in several 
countries in Southeast Asia (Nesper eta/., 2002, Nair et al., 1994). However, beginning in 
1994, 0 I EI Tor strains have re-emerged as the predominant cholera causing organisms on 
the Indian subcontinent, although 0139 strains continue to co-exist (Nesper eta/., 2002). 
Vibrio cholerae OI and OI39 are commonly known to carry a set of virulence 
genes necessary for pathogenesis in humans. Recent studies have indicated that virulence 
genes or their homologues are also dispersed among environmental strains of V. cho/erae 
belonging to diverse serogroups that appear to constitute an environmental reservoir of 
virulence genes. Although the roles of virulence-associated factors in the environment and 
the selection pressures for environmental V. cholerae carrying virulence genes is not clear, 
it is possible that these strains may be precursors of pathogenic strains or may participate in 
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gene transfer events leading to the origination of pathogenic strains (Faruque et al., 2004 ). 
Many genes associated with virulence in cholera are now known to have been acquired 
through gene-transfer events that have mediated the transformation of avirulent strains to 
those capable of causing outbreaks of diarrhea (Uma et al., 2003). The acquisition of key 
virulence genes by horizontal transfer events is important in the evolution of pathogenic 
strains of V. cholerae. Such a genetic transfer event preceded the 1992 emergence of a 
novel serogroup of epidemic cholera, Vibrio cholerae 0139, which arose through the 
acquisition of the wbf gene cluster from a nontoxigenic V. cholerae isolate (Alam et al., 
2005). 
The appearance of the 0139 serogroup, which shares ominous similarities with that 
of the 01 serogroup, has several implications. For instance, until recently, only 01 Vibrio 
cholerae strains were considered to cause cholera while the non-0 1 Vibrio cholerae strains 
and other enteric pathogens caused only a cholera-like infection. However, G. Balakrish 
Nair (1994) proposed that the disease caused by 0139 strains should be designated as 
cholera and should be a disease notifiable to the World Health Organization because of the 
similarity in the clinical profile of the disease and because of the epidemic potential of the 
0139 serogroup, which is identical to that of the 01 serogroup (Nair et al., 1994). 
From previous studies, several lines of evidence suggested that the 0139 serogroup 
closely resembles the 01 El Tor biotype. However, there are also several differences 
between 0139 and 01 serogroups. Existing data suggest that serogroup 0139, synonymous 
with Bengal arose from a serogroup 01 biotype El Tor, lack the 0 !-specific antigen. So, 
non-agglutinability of the strains with 01 antiserum was the main differences between 
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